What is the incidence of placenta accreta syndrome among primigravid (first-time pregnant) women in a specific location?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Placenta Accreta Spectrum Among Primigravid Women

The incidence of placenta accreta spectrum (PAS) among primigravid women is extremely low, approximately 0.3% or less, as first-time pregnant women lack the primary risk factor of prior uterine surgery. 1

Understanding the Baseline Risk in Primigravidas

The overall incidence of PAS in the United States is currently 1 in 272 birth-related hospital discharges, representing a dramatic increase from historical rates of 1 in 2,510 to 1 in 4,017 pregnancies. 2, 1 However, this population-level statistic is heavily skewed by high-risk patients with prior cesarean deliveries and other uterine surgeries.

For primigravid women specifically, the risk is substantially lower because they lack the most significant risk factor: prior cesarean delivery. 1, 3 The evidence demonstrates that:

  • In the general population without placenta previa, the risk of PAS is approximately 0.3% with one prior cesarean delivery. 1
  • This 0.3% figure represents women who have already had one uterine surgery, meaning primigravidas without any prior uterine intervention would have even lower baseline risk. 1

Risk Stratification for First-Time Mothers

While primigravid status confers protection, certain risk factors can still elevate PAS risk even in first pregnancies:

  • Placenta previa alone (without prior cesarean) carries a 3% risk of PAS. 1, 4
  • In vitro fertilization is an independent risk factor that can affect primigravidas. 1, 5
  • Prior uterine curettage (such as for miscarriage management) increases risk even in first viable pregnancy. 1, 5
  • Advanced maternal age and multiparity are additional factors, though multiparity by definition excludes true primigravidas. 2, 1

Critical Clinical Caveat

The absence of prior cesarean delivery does not eliminate PAS risk entirely. 5 Uterine body PAS can occur in primigravid women, particularly those with:

  • History of uterine curettage for pregnancy loss 5
  • Asherman's syndrome 1, 5
  • Prior myomectomy with endometrial cavity entry 6
  • Endometritis history 5
  • Uterine leiomyoma 5

These cases are particularly dangerous because they are easily missed on prenatal ultrasound, with only 3% diagnosed pre-symptomatically, and up to 45% presenting with signs of uterine rupture even before 24 weeks viability. 5

Location-Specific Considerations

The incidence data provided reflects U.S. population statistics. 2, 1 The specific location mentioned in your question would require local epidemiological data, as PAS incidence varies based on:

  • Regional cesarean delivery rates (the primary driver of PAS incidence) 3, 7
  • Access to assisted reproductive technologies 7
  • Maternal age demographics 7
  • Prevalence of prior uterine procedures 7

In summary, primigravid women have the lowest risk profile for PAS, with incidence well below 0.3% in the absence of placenta previa or other uterine risk factors, but screening remains essential when any risk factors are present. 1, 3

References

Guideline

Incidence and Risk Factors of Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing and Managing Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Placenta Accreta Spectrum: Epidemiology and Risk Factors.

Clinical obstetrics and gynecology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.